Biology subjects

Chaves-Filho, A. B.

Publications and source records attributed to Chaves-Filho, A. B..

3 recordsLinked to original sources

bioRxiv2025

Oxysterol Alterations in SOD1G93A ALS Rats: 25-Hydroxycholesterol and LPS-Binding Protein in Disease Progression

BackgroundDisruptions in cholesterol and oxysterol metabolism, along with neuroinflammation, are linked to amyotrophic lateral sclerosis (ALS), though the underlying mechanisms remain unclear. Given evidence of increased intestinal permeability in ALS, we investigated its link to neuroinflammation and oxysterol alterations in SOD1G93A rats. MethodsOxysterols were quantified in plasma and spinal cord from presymptomatic and symptomatic SOD1G93A rats and age-matched controls via ultra-high performance liquid chromatography coupled with high-resolution mass spectrometry. Circulating LBP, a marker of intestinal permeability, was quantified via ELISA. ResultsOxysterols involved in bile acid biosynthesis - 7-hydroxycholesterol, 27-hydroxycholesterol (27-OH), and 3{beta}-hydroxycholestenoic acid - were increased in the plasma of symptomatic rats. The neuronal oxysterol 24(S)-hydroxycholesterol (24(S)-OH) decreased in the spinal cord but increased in the plasma. In contrast, 27-OH and 25-hydroxycholesterol (25-OH) levels were elevated in both plasma and spinal cord, with 25-OH rising during the presymptomatic stage. Presymptomatic animals also exhibited elevated LBP levels, which strongly correlated with spinal cord 25-OH levels, suggesting a link between systemic inflammation and neuroinflammation in ALS. ConclusionOxysterol alterations in plasma and spinal cord suggest compromised blood-spinal cord barrier integrity and early neuroinflammation. Elevated LBP levels indicate increased intestinal permeability and circulating LPS as contributors to neuroinflammation and neurodegeneration. These findings highlight 25-OH and LBP as markers and mediators of gut-brain axis interactions in ALS pathogenesis, particularly in the presymptomatic phase.

neuroscience↗

bioRxiv2024

Comparative study of Ergosterol and 7-dehydrocholesterol and their Endoperoxides: Generation, Identification and Impact in Phospholipid Membranes and Melanoma Cells

Melanoma is an aggressive cancer that has attracted attention in recent years due to its high mortality rate of 80%. Damage caused by oxidative stress generated by radical (type I reaction) and singlet oxygen, 1O2 (type II reaction) oxidative reactions may induce cancer. Thus, studies that aim to unveil the mechanism that drives these oxidative damage processes become relevant. Ergosterol, an analogue of 7-dehydrocholesterol, important in the structure of cell membranes, is widely explored in cancer treatment. However, to date little is known about the impact of different oxidative reactions on these sterols in melanoma treatment, and conflicting results about their effectiveness complicates the understanding of their role in oxidative damage. Our results highlight differences among ergosterol, 7-dehydrocholesterol (7-DHC) and cholesterol in membrane properties when subjected to distinct oxidative reactions. Furthermore, we conducted a comparative study exploring the mechanisms of cell damage by photodynamic treatment in A375 melanoma. Notably, endoperoxides from ergosterol and 7-DHC generated by 1O2 showed superior efficacy in reducing the viability of A375 cells compared to their precursor molecules. We also describe a step-by-step process to produce and identify endoperoxides derived from ergosterol and 7-DHC. While further studies are needed, this work provides new insights for understanding cancer cell death induced by different oxidative reactions in the presence of biologically relevant sterols.

biochemistry↗

bioRxiv2023

Plasma Oxylipin Profiling by High Resolution Mass Spectrometry Reveal Signatures of Inflammation and Hypermetabolism in Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized not only by progressive loss of motor neurons, but also linked to systemic hypermetabolism, oxidative stress, and inflammation. In this context, oxylipins have been investigated as signaling molecules linked to neurodegeneration. However, the nature and role of major oxylipins involved in ALS disease progression remain unclear. Importantly, most methods focused on oxylipin analysis are based on low resolution mass spectrometry (LRMS), which usually confers high sensitivity, but not great accuracy for lipid identification, as provided by high-resolution MS (HRMS). Here, we established an ultra-high performance liquid chromatography coupled HRMS (LC-HRMS) method for simultaneous analysis of 126 oxylipins in plasma, including lipid hydroxides, ketones, epoxides, prostaglandins, leukotrienes, and others in a 15-minute run. Intra- and inter-day method validation showed high sensitivity (0.3 - 25 pg), accuracy and precision for more than 90 % of quality controls. This method was applied for the analysis of oxylipins in plasma of ALS rats overexpressing the mutant human Cu/Zn-superoxide dismutase gene (SOD1-G93A) at asymptomatic (ALS 70 days old) and symptomatic stages (ALS 120 days old), and their respective age-matched wild type controls (WT 70 days old and WT 120 days old). From the 56 oxylipins identified in plasma, 17 species were significantly altered. Remarkably, most of oxylipins linked to inflammation and oxidative stress derived from arachidonic acid, such as, prostaglandins, lipoxins, mono-hydroxides, and isoprostane, were increased in ALS 120d rats. In contrast, the linoleic acid diols involved in fatty acid uptake and {beta}-oxidation, 9(10)-DiHOME and 12(13)-DiHOME, were strongly decreased in the ALS 120d. In summary, we developed and validated a high-throughput LC-HRMS method for oxylipin analysis and provided a comprehensive overview of plasma oxylipins involved in ALS disease progression. Noteworthy, the oxylipins altered in plasma of ALS 120d rats have potential to be investigated and used as biomarkers for inflammation and hypermetabolism in ALS. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=136 SRC="FIGDIR/small/547101v1_ufig1.gif" ALT="Figure 1"> View larger version (40K): org.highwire.dtl.DTLVardef@937099org.highwire.dtl.DTLVardef@1c5847forg.highwire.dtl.DTLVardef@7dd09borg.highwire.dtl.DTLVardef@a9f8d_HPS_FORMAT_FIGEXP M_FIG C_FIG

biochemistry↗